Quist SR et al. |
Effects of Topical Tacrolimus and Polyunsaturated Fatty Acids on In Vivo Release of Eicosanoids in Atopic Dermatitis During Dermal Microdialysis. |
2016 |
Acta Derm. Venereol. |
pmid:26911315
|
Hartmann A et al. |
Treatment of generalised vitiligo with tacrolimus 0.1% ointment vs. UVB intense pulsed light phototherapy: a pilot study. |
2014 |
Acta Derm. Venereol. |
pmid:24473666
|
Cunha PR |
Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. |
2006 |
Acta Derm. Venereol. |
pmid:16585998
|
Cunha PR and Rossi AB |
Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. |
2006 |
Acta Derm. Venereol. |
pmid:16585999
|
Larsen CG and Thyssen JP |
Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment. |
2012 |
Acta Derm. Venereol. |
pmid:21681352
|
Jacobs F et al. |
New approach in combined therapy of perifolliculitis capitis abscedens et suffodiens. |
2011 |
Acta Derm. Venereol. |
pmid:21681358
|
Chittock J et al. |
Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. |
2015 |
Acta Derm. Venereol. |
pmid:25594610
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Mrowietz U et al. |
An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion. |
2003 |
Acta Derm. Venereol. |
pmid:14609102
|
Kim TW et al. |
Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial. |
2013 |
Acta Derm. Venereol. |
pmid:23388687
|